These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Memory function of patients taking etryptamine acetate. BYLENGA ND; MAY RH J Nerv Ment Dis; 1961 Sep; 133():213-5. PubMed ID: 13875315 [No Abstract] [Full Text] [Related]
5. Depression--its treatment with etryptamine acetate. SETTEL E J Am Geriatr Soc; 1961 Sep; 9():755-8. PubMed ID: 13750393 [No Abstract] [Full Text] [Related]
6. Etryptamine acetate in general practice. CHOGICH JC J Neuropsychiatr; 1961; 3():96-7. PubMed ID: 13879126 [No Abstract] [Full Text] [Related]
7. Treatment of geriatric patients with etryptamine acetate. KIESSLING AJ J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873 [No Abstract] [Full Text] [Related]
8. Studies on the toxicology of alpha-methyl- and alpha-ethyltryptamine acetates (Monase). II. Chronic studies. KELLER JG; VIGUERA C; KUNDZINS W Toxicol Appl Pharmacol; 1962 Nov; 4():697-709. PubMed ID: 14031765 [No Abstract] [Full Text] [Related]
9. [ON THE EFFECT OF THE OPTICAL ISOMERS OF ETHYLTRYPTAMINE ACETATE ON POSTURAL CATALEPSY IN CHICKENS AND ON MOTILITY IN MICE]. VOGEL G; THER L Arzneimittelforschung; 1963 Sep; 13():779-83. PubMed ID: 14114483 [No Abstract] [Full Text] [Related]
10. CHEMICALLY (TCP) INDUCED FIBRE DEGENERATION IN THE CENTRAL NERVOUS SYSTEM, WITH REFERENCE TO CLINICAL AND NEUROPHARMACOLOGICAL ASPECTS. GLEES P; JANZIK H Prog Brain Res; 1965; 14():97-121. PubMed ID: 14317763 [No Abstract] [Full Text] [Related]
11. A neuropharmacological investigation piperdine (1762 IS). LONGO VG; CORRADO AP Proc Soc Exp Biol Med; 1961 Jun; 107():272-4. PubMed ID: 13763381 [No Abstract] [Full Text] [Related]
12. [Etryptamine, a new designer drug with a fatal effect]. Daldrup T; Heller C; Matthiesen U; Honus S; Bresges A; Haarhoff K Z Rechtsmed; 1986; 97(1):61-8. PubMed ID: 3776356 [TBL] [Abstract][Full Text] [Related]
13. [Antireserpinic activity of 2 new psychoenergizing drugs: tranylcypromine (SKF 385) and etryptamine (Monase)]. GOLDWURM GF; TORRIGIANI G Riv Sper Freniatr Med Leg Alien Ment; 1961 Dec; 85():1331-52. PubMed ID: 13948833 [No Abstract] [Full Text] [Related]
14. Neuropharmacology of procaine. II. Central nervous actions. PETERSON CG Anesthesiology; 1955 Nov; 16(6):976-93. PubMed ID: 13268913 [No Abstract] [Full Text] [Related]
15. Clinical experiences with etryptamine in office practice. MALETZ L J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():58-60. PubMed ID: 13765760 [No Abstract] [Full Text] [Related]
16. [The raised maze test used as neuropharmacological test]. BLOZOVSKI M C R Hebd Seances Acad Sci; 1959 Dec; 249():2868-70. PubMed ID: 13801655 [No Abstract] [Full Text] [Related]
17. [Neuropharmacology; central mechanisms of action of chemical substances and their neurophysiological principles]. JUNG R Klin Wochenschr; 1958 Dec; 36(24):1153-67. PubMed ID: 13621594 [No Abstract] [Full Text] [Related]
18. Etryptamine, a new and safer antidepressant chemical. ROBIE TR Dis Nerv Syst; 1961 Aug; 22():452-6. PubMed ID: 13742241 [No Abstract] [Full Text] [Related]
19. Alpha-ethyltryptamine acetate in alcoholism. A preliminary report. LAWRENCE FE J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():88-90. PubMed ID: 13759684 [No Abstract] [Full Text] [Related]